MedPath

Performance test of a diagnostic support program for evaluating the depth of invasion of early gastric cancer

Not Applicable
Conditions
early gastric cancer
D013274
Registration Number
JPRN-jRCT1060220108
Lead Sponsor
Kawahara Yoshiro
Brief Summary

We calculated the sensitivity of the program to M cancer. The estimated value was 91.2% (124/136), and the two-sided 95% confidence interval (Wilson) was 85.2% to 94.9%. The lower limit of the confidence interval exceeded the target of 75% and was 85.2%. The estimated value of specificity was 66.2% (45/68), and the lower limit of the one-sided 95% confidence interval was higher than 56.3% and 54%, demonstrating non-inferiority with p<0.001.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
204
Inclusion Criteria

1. Individuals who are 20 years of age or older at the time of endoscopic image acquisition.
2. Individuals who can provide early gastric cancer tissue suitable for pathological diagnosis by a pathological evaluator.
3. Individuals who can provide images that meet the following criteria for endoscopic images:
Images captured using White Light mode
Vertical resolution of 700 pixels or more and horizontal resolution of 800 pixels or more (image area)
Images captured using an Olympus or Fujifilm endoscope
Five or more images per lesion
Suitable for deep depth diagnosis, as shown below
The entire gastric tumor is generally visible (without using close-up or magnifying endoscopy, etc.)
The details of the tumor's shape can be observed (without moving the lens too far from the tumor)
Sufficient insufflation is performed.

Exclusion Criteria

1. The following images are excluded
Images that do not show the gastric tumor (such as normal areas)
Images taken after treatment such as biopsy or clipping, or images with severe bleeding
Images that show foreign objects such as food residue
Blurred or unclear images due to poor focus or other factors
Images that only show a portion of the lesion due to magnifying endoscopy or close-up photography
2. Individuals who have undergone gastric resection or gastric tube reconstruction at the time of endoscopic image acquisition or specimen collection.
3. Individuals with lesions extending to the esophagus or duodenum at the time of endoscopic image acquisition or specimen collection.
4. Individuals with a history of chemotherapy or radiation therapy to the upper abdomen within the year prior to the target endoscopic examination.
5. Patients who have refused to participate in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity of mucosal gastric cancer (M cancer) diagnosed by this program.
Secondary Outcome Measures
NameTimeMethod
1) Specificity of mucosal gastric cancer (M cancer) diagnosed by this program.<br>2) Diagnostic accuracy rate of mucosal gastric cancer (M cancer) diagnosed by this program.
© Copyright 2025. All Rights Reserved by MedPath